Wegovy contains the same active drug (semaglutide) as Ozempic, but Wegovy is not used for type 2 diabetes
Is tirzepatide dosing different for men and women
The Personalized Compounding Exemption Federal law allows compounding for individual patients when a prescriber determines it's necessary While FDA guidance is more restrictive than the law, it still provides a path for personalized GLP-1 dosages Hims appears to be following the legal framework by offering semaglutide doses different from commercial options The principal legal basis for personalized compounding of GLP-1 drugs can be found in the Food, Drug, and Cosmetics Act (FDCA), specifically in 21 U.S
In 2023 and 2024 , respectively, Ozempic and Wegovy were also approved to reduce the risk of major cardiovascular problems (e.g
Medical supervision makes the critical difference in semaglutide treatment outcomes
Semaglutide is given as a weekly injection, which many people find easy to use at home